Powder extensively hydrolysed formula (0913101) vs Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344)
Powder extensively hydrolysed formula (0913101) was dispensed 41,759.0× as often as Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344) in March 2026 — 41,759 items versus 1 in England.
41,759items
Powder extensively hydrolysed formula (0913101) · March 2026
NHSBSA Prescription Cost Analysis
1items
Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344) · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Powder extensively hydrolysed formula (0913101) versus Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344): national items dispensed by month
▬ Powder extensively hydrolysed formula (0913101) · ╌ Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344)
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Powder extensively hydrolysed formula (0913101) | Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344) |
|---|---|---|
| Items, March 2026 | 41,759 | 1 |
| Items, last 12 months | 490,419 | 17 |
| Net ingredient cost, March 2026 | £3,118,227 | £117 |
See the full profile for Powder extensively hydrolysed formula (0913101) or Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344).